Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by smartbroker12on Dec 16, 2017 7:33pm
285 Views
Post# 27172417

Buy Valeant Pharmaceuticals before it becomes too expensive

Buy Valeant Pharmaceuticals before it becomes too expensive Valeant is standing at 8.8Billion valuation way above the industry peer in Cannabis Industry. Just one news about becoming the "Cannabis licensed producer"  and stock price will jump many fold. 

Recently stock increased from $20 to 28 and back to $25. Not to forget the highs of $350 last year. 

Soruce: 

                                                                                                Numbers are in Millions
Valeant Pharmaceuticals International Inc (CAD) 8,850
Canopy Growth Corp (CAD) 3,626
Aurora Cannabis Inc (CAD) 2,680
Aphria Inc (CAD) 2,179
MedReleaf Corp (CAD) 1,513 


Link: https://cobrands.morningstar.ca/ProfileService/report/pdf/7AVeC9IEuZ/en-CA/0P000067ZC/ST/Quote
Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.weed&postid=27172414#CDiuOWX2bv0GhsKP.99
Bullboard Posts